The Medical Advisory Committee met on the 6th March 2015 to review the TruScreen Ultra prototype.
Medical Advisory Committee members attending the review included Chairman Professor Neville Hacker AM, Dr Michael Campion and Dr Elivra Bardon. Other attendees at the review were TruScreen CEO Martin Dillon, Chief Technologist Dr John Blakemore and GM Operations Paul Curran.
The Medical Advisory Committee were pleased with the development of the new device and look forward to seeing the device in market saving the lives of women throughout the world.